New method to measure telomerase activity by transcription-mediated amplification and hybridization protection assay

Clinical Chemistry

Volumn 44, Issue 12, 1998, Pages 2446-2452

  Hirose, Minoru ^a   Abe Hashimoto, Junko ^a   Tahara, Hidetoshi ^b   Ide, Toshihide ^b   Yoshimura, Tadashi ^a  

^a Chugai Diagnostics Science Co Ltd   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; CELL STRAIN HL 60; CELL STRAIN K 562; ENZYME ASSAY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HYBRIDIZATION;

CARCINOMA, HEPATOCELLULAR; COLORECTAL NEOPLASMS; DNA PRIMERS; HUMANS; LIVER NEOPLASMS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; NUCLEIC ACID HYBRIDIZATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TELOMERASE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031672718     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Greider CW, Blackburn EH. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987;51:887-98.
2. Morin GB. The human telomere terminal transfer as enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59:521-9.
3. Wilkie AOM, Lamb J, Harris PC, Finney RD, Higgs DR. A truncated human chromosome 16 associated with δ thalassaemia is stabilized by addition of telomeric repeat (TTAGGG)n. Nature 1990; 346:868-71.
4. Blackburn EH. Structure and function of telomeres. Nature 1991; 350:569-73.
5. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992;11:1921-9.
6. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci U S A 1994;91: 2900-4.
7. Prowse KR, Avilion AA, Greider CW. Identification of a nonprocessive telomerase activity from mouse cells. Proc Natl Acad Sci U S A 1993;90:1493-7.
8. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
9. Hiyama E, Hiyama K, Yokoyama T, Matuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995;1:1-15.
10. Hiyama K, Hiyama E, Ishikawa S, Yamakido M, Inai K, Gazdar AF, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995;87:895-902.
11. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova S, Shay JW, Coffey DS. Telomerase activity: a prevalent marker of malignancy in human colorectal cancer. Cancer Res 1996;56:218-22.
12. Tahara H, Kuniyasu H, Yokozaki H, Yasui W, Shay JW, Ide T, Tahara E. Telomerase activity in preneoplastic and gastric and colorectal lesions. Clin Cancer Res 1995;1:1245-51.
13. Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995;23:3794-5.
14. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996;88:116-22.
15. Hirose M, Hashimoto JA, Ogura K, Tahara H, Ide T, Yoshimura T. A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol. J Cancer Res Clin Oncol 1997;123:337-44.
16. Arnold LJ, Hammond PW, Wiese WA, Nelson NC. Assay formats involving acridinium-ester-labeled DNA probes. Clin Chem 1989; 35:1588-94.
17. Dhingra K, Talpaz M, Riggs M, Eastman PS, Zipf T, Ku S, Kurzrock R. Hybridization protection assay: a rapid, sensitive, and specific method for detection of Philadelphia chromosome-positive leukemias. Blood 1991;77:238-42.
18. Kacian DL, Fultz TJ, inventors. Nucleic acid sequence amplification methods. Patent application no. PCT/US91/03184, filed February 7, 1991.
19. McDonough SH, Bott MA, Giachetti C. Application of transcription-mediated amplification to detection of nucleic acids from clinically relevant organisms. In: Lee H, Morse S, Olsvik Ø, eds. Nucleic acid amplification technologies. Natick, MA: BioTechniques Books, 1998:113-23.
20. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995;55:2734-6.
21. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE, Shay JW. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 1995;17:1-15.
22. Harley CB, Kim N, inventors. Telomerase activity assays. Patent application no. PCT/US96/09669, June 7, 1996.
23. Tatematsu K, Nakayama J, Danbara M, Shinoya S, Sato H, Omine M, Ishikawa F. A novel quantitative stretch PCR assay that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias. Oncogene 1996;13:2265-74.
24. Krupp G, Kuhne K, Tamm S, Klapper W, Heidorin K, Rott A, Parwaresch R. Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust TRAP assay. Nucleic Acids Res 1997;25:919-21.
25. Kim NW, Wu F. Advances in quantification and characterization of telomerase activity by telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 1997;25:2595-7.
26. Kamisango K, Ohtsuka M, Tsuji Y, inventors. Patent application no. PCT WO 9624044, filed August 8, 1996.
27. Nelson NC, Cheikh AB, Matsuda E, Becker MM. Simultaneous detection of multiple nucleic acid targets in a homogeneous format. Biochemistry 1996;35:8429-38.